Summary
The FDA has recalled the blood pressure drug prazosin, manufactured by Teva Pharmaceuticals, because it contains high levels of cancer-causing chemicals called nitrosamines. The recall affects more than 580,000 capsules and was announced on October 7, 2025. Prazosin is used to treat conditions like high blood pressure and post-traumatic stress disorder.
Key Facts
- The FDA recalled prazosin due to elevated nitrosamine levels.
- Nitrosamines are chemicals that can increase cancer risk with long-term exposure.
- The recall involves over 580,000 capsules made by Teva Pharmaceuticals.
- About 510,000 patients are prescribed prazosin each year.
- Prazosin is a generic drug available for over 25 years.
- Only Teva's version of prazosin is affected by the recall.
- Teva announced the recall on October 7, 2025.
- Patients can check if their prazosin is from Teva by looking at the prescription label for the manufacturer details.
